Prosecution Insights
Last updated: April 19, 2026
Application No. 17/949,484

CURABLE COMPOUNDS AND FORMULATIONS FOR BIOMEDICAL APPLICATIONS

Non-Final OA §103
Filed
Sep 21, 2022
Examiner
PIPIC, ALMA
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
3D Systems, Inc.
OA Round
3 (Non-Final)
55%
Grant Probability
Moderate
3-4
OA Rounds
3y 1m
To Grant
99%
With Interview

Examiner Intelligence

Grants 55% of resolved cases
55%
Career Allow Rate
380 granted / 696 resolved
-5.4% vs TC avg
Strong +57% interview lift
Without
With
+56.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
57 currently pending
Career history
753
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
40.6%
+0.6% vs TC avg
§102
10.2%
-29.8% vs TC avg
§112
32.2%
-7.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 696 resolved cases

Office Action

§103
--DETAILED ACTION-- Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant’s submission filed on February 25, 2026 has been entered. Priority This application claims benefit in provisional application 63/246,604 filed on 09/21/2021. Claim Status Claims 1-3, 7-12, 14-20, and 22-24 are pending. Claims 17-20 remain withdrawn. Claims 4-6, 13, and 21 were canceled. Claims 23 and 24 were newly added and read on the elected invention of Group I. Claims 1-3, 7-12, 14-16, and 22-24 are examined. Claim Rejections - 35 USC§ 103 Rejections of claims 1-3, 7-10, 14-16, and 22 over Denzinger (CA 2,038,332 Published September 18, 1991) and evidenced by Krause (EP 2 559 723 Al Published February 20, 2013) are withdrawn because applicant amended claim 1 by incorporating limitations of claim 21, which are not obvious over the cited references; and rejection of claim 21 over Denzinger as evidenced by Krause and further in view of Matsuo (Patent 6,699,830 B 1 Date of Patent March 2, 2004) is withdrawn after further consideration. Denzinger limits the concentration range of crosslinker to 0.05-5 wt. % based on the total amount of monomers used in the polymerization. It would not have been obvious to the skilled artisan to extend the concentration range to 0.0005-20 wt. % by weight of all the monomers as taught by Matsuo. Claim Rejections - 35 USC§ 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Claims 1-3, 7-12, 14-16, and 22-24 are rejected under 35 U.S.C. 103 as being unpatentable over Palchik (WO 2015/015500 Al Published February 5, 2015) and Denzinger (CA 2,038,332 Published September 18, 1991) as evidenced by Sartomer (Technical Data Sheet for SR610 polyethylene glycol (600) diacrylate, accessed from https://americas.sartomer.arkema.com/assets/arkema/TDS_SR610_MDM-11109-00-AM_en_WW.pdf, accessed on July 8, 2025, 1 page). The claims encompass a polymerizable liquid for hydrogel article formation comprising a compound of formula I or formula II; an acrylate component comprising one or more hydroxyalkylacrylates; and water. The teachings of Palchik are related to a hydrogel and methods of making (Abstract). Paragraphs 0021 and 0022 describe methods of making the hydrogel where a monomeric or oligomeric mixture is irradiated to form a hydrogel. The monomeric or oligomeric mixture further comprises a solvent, where the solvent is water. The solvent is present at an amount of up to 20% w/w of the reaction mixture (paragraphs 0023 and 0033). The mixture comprises 10-80 wt. % of monomers and oligomers (paragraphs 0039 and 0043). In some embodiments the solvent is added to the mixture in a concentration of about 1-50 wt. %, where solvent includes water (paragraph 0044). In one embodiment, the hydrogel is formed by mixing one or more monofunctional monomers with one or more multifunctional monomers or oligomers (paragraphs 0056 and 0060). The mixture comprises 1-50 wt. % of solvent such as water. The monofunctional or multifunctional monomers or oligomers may be present in the mixture in a concentration of 30% and up to 70% by weight (paragraph 0057). The mixture further comprises a photoinitiator (paragraph 0058). Examples of monofunctional monomers include acrylate monomers (paragraph 0079). Examples of acrylate monomers include 2-hydroxyethyl acrylamide and 2-hydroxyethyl acrylate (paragraph 0081). Examples of multifunctional monomers include tetraethylene glycol diacrylate and polyethylene glycol diacrylate (e.g. SR6 l 0) (paragraph 0085). The photoinitiator is present in a concentration of 0.1-10 wt. % (paragraph 00102). Tables 1 and 2 in paragraph 00157 describe compositions used for making the hydrogel: PNG media_image1.png 186 649 media_image1.png Greyscale PNG media_image2.png 99 516 media_image2.png Greyscale Palchik does not teach a compound having the structure of Formula I. The teachings of Denziger are related to copolymers obtained by free radical polymerization of (a) monoethylenically unsaturated dicarboxylic acids, (b) hydroxy-C2-C4- alkyl acrylates and optionally (c) other water-soluble monoethylenically unsaturated monomers (Abstract). The monomers of group (a) are present in the copolymer in the concentration of at least 65% by weight (page 3 lines 15-30). Monomers of group (b) include 2-hydroxyethyl acrylate, among others (paragraph bridging pages 3-4). Monomers of group (c) include acrylic acid and acrylamide, among others (page 4 lines 8-34). The copolymers further comprise monomers of group (d) in an amount of up to 5 wt. % based on the total amount of monomers used in the polymerization. The monomers of group (d) are crosslinkers including polyethylene glycol diacrylates derived from polyalkylene glycols of molecular weight of 96-2000, and polyethylene glycol dimaleates of polyethylene glycol having a molecular weight of up to 2000 (page 5 lines 7-29). The monomers are subject to a polymerization initiated with a free radical initiator such as azo compound and peroxides. This also includes redox systems. Preference is given to sodium persulfate and hydrogen peroxide (page 6 lines 9-17). The initiators are used in a concentration of 0.5-20 % by weight based on the monomers (page 6 lines 35-37). The polymerization is carried out in an aqueous solution of the monomers. The concentration of the monomers in the aqueous solution s 10-70 wt. % (page 7 lines 8-11). The teachings of Denzinger and Palchik and related to liquid compositions comprising a photoinitiator, water, an acrylate monomer, and polyethylene glycol diacrylate crosslinker, wherein the compositions are intended for polymerization and it would have been obvious to have combined their teachings because they are in the same field of endeavor. Regarding claims 1-3, it would have been prima facie obvious to a person of ordinary skill in the art before the effective filing date of the claimed invention to have formed a mixture for making a hydrogel, the mixture comprising one or more monofunctional monomers, one or more multifunctional monomers, a solvent, and a photoinitiator, with a reasonable expectation of success because Palchik teaches a mixture intended for making a hydrogel wherein the mixture comprises one or more monofunctional monomers, one or more multifunctional monomers or oligomers, a solvent, and a photoinitiator. It would have been obvious to have selected 2- hydroxyethyl acrylate as the one or more monofunctional monomers because Palchik teaches 2- hydroxyethyl acrylate as a suitable monofunctional monomer. It would have been obvious to have selected polyethylene glycol diacrylate SR6 l 0 as the multifunctional oligomer because Palchik teaches polyethylene glycol diacrylate SR610 as a suitable multifunctional oligomer. It would have been obvious to have selected water as the solvent because Palchik teaches water as a suitable solvent. As evidenced by Sartomer, SR610 is polyethylene glycol (600) diacrylate, which corresponds to 13 ethylene glycol repeating units. It would have been obvious to have modified Palchik's composition by replacing polyethylene glycol (600) diacrylate with polyethylene glycol (mw up to 2000) dimaleate, with a reasonable expectation of success because it was known from Denzinger that polyethylene glycol diacrylate and polyethylene glycol dimaleate are known as suitable crosslinkers of acrylate monomers such as 2- hydroxyethyl acrylate, and replacing one equivalent with another to obtain predictable results supports obviousness. PEG having a molecular weight of up to 2000 contains up to 45 ethylene glycol repeating units, which meets the requirements of the claimed compound of formula I. It would have been obvious to have used the crosslinker in a concentration of 30 wt.% because Palchik teaches using SR610 in a concentration of 30 wt.% based on the total polymerization mixture (Experiment No. 3 in Table 1). The claimed concentration ranges of the compound of Formula I in claims 1 and 3 are obvious because they encompass 30 wt.%. Regarding claim 7, it would have been obvious to have used 2-hydroxyethyl acrylate monomer in the composition in a concentration from 30 wt.% to 70 wt.%, with a reasonable expectation of success because Palchik teaches that monomers are present in the composition in range of 30-70 wt.% based on the total weight of the composition. The claimed concentration range is obvious because it overlaps with the prior art range. Regarding claim 8, it would have been obvious to have formed the liquid composition with water in a concentration of 1-50 wt. %, with a reasonable expectation of success because Palchik teaches 1-50 wt.% as a suitable concentration range of water in the liquid composition. Regarding claim 9, it would have been obvious to have formed the liquid formulation with an additional monomer such as acrylic acid, with a reasonable expectation of success Palchik teaches forming the polymer form a combination of monomers including acrylates and acrylic acid (paragraphs 0078 and 0081). Regarding claim 10, it would have been obvious to have varied the concentrations of 2- hydroxyethyl acrylate and the additional monomer acrylic acid in a range of up to 70 wt. % as long as the combined concentration of the two falls in the range of 30-70 wt. % based on the total weight of the composition. Palchik does not require specific monomers to be present in a specific concentration range, however Palchik teaches that monomers are present in a range of 30-70 wt. %. It would have been obvious to have varied the concentration of each monomer in range ofup to 70 wt. % as long as the combined concentration falls within Palchik' s total monomer requirement. The concentration range in claim 10 is obvious because it overlaps with a range of up to 70 wt. %. Regarding claim 11, it would have been obvious to have added a pigment to the liquid composition because Palchik teaches that the polymer composition further comprises additives such as pigments (paragraph 00104), and the skilled artisan would have understood that the pigment would have to be added to the polymerization mixture in order to forma a polymer fiber that comprises a pigment. Regarding claim 12, Palchik teaches a composition comprising water in a concentration of 1-50 wt.%, monomers in a concentration of 30-70 wt.% and crosslinker in a concentration of 30 wt.%. It would have been obvious to have added a pigment in a concentration of up to 39 wt. % because the lowest concentration ranges of the required components water, monomers, and crosslinker add up to 61 wt.%, which means that the remainder of the composition may comprise other components such as additives including a pigment. The claimed concentration range is obvious because it overlaps with the prior art range of up to 39 wt. %. The skilled artisan would have been capable of determining suitable concentrations of each component through routine experimentation. Regarding claim 14, it would have been obvious to have added the photoinitiator in a concentration of 0.1-10 wt. % of an uncured composition mixture based upon the weight of the composition, with a reasonable expectation of success because Palchik teaches said concentration range as suitable (paragraph 00102). The claimed range is obvious because it overlaps with the prior art range. Claims 15 and 16 describe properties of a material obtained when the liquid composition of claim 1 is polymerized. Palchik' s modified liquid composition contains the same elements as claimed, and it would have been reasonable to expect a material obtained from Palchik' s liquid formulation to have the same properties as a material obtained by polymerization of the claimed liquid formulation, when the claimed and Palchik's liquid formulations are polymerized under identical conditions. Regarding claim 22, it would have been obvious to have used 2-hydroxyethyl acrylate monomer in the composition in a concentration from 30 wt.% to 70 wt.%, with a reasonable expectation of success because Palchik teaches that monomers are present in the composition in range of 30-70 wt. % based on the total weight of the composition. The claimed concentration range is obvious because it overlaps with the prior art range. It would have been obvious to have formed the liquid composition with water in a concentration of 1-50 wt. %, with a reasonable expectation of success because Palchik teaches 1- 50 wt. % as a suitable concentration range of water in the liquid composition. Regarding claims 23 and 24, it would have been obvious to have selected benzophenone as the photoinitiator with a reasonable expectation of success because Palckik teaches benzophenone as a suitable photoinitiator (paragraph 00100). The specification was reviewed and there is no evidence that claimed combinations of elements and concentration ranges are critical. The claimed invention is obvious because combining prior art elements according to known methods to obtain predictable results supports obviousness. Response to Arguments Arguments submitted in the remarks dated February 25, 2026 were fully considered but are not persuasive for the following reasons. Rejections over Palchik, Denzinger, and Sartomer are maintained because claim 21 was rejected over these references, see page 13 of the final office action. Claims 21 and 22 were inadvertently left out of the rejection statement, however it is clear from the body of the rejection that claims 21 and 22 were rejected over these references. Conclusion No claims are allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Alma - Pipic whose telephone number is (571)270-7459. The examiner can normally be reached M-F 9:00am-5:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner's supervisor, Michael Hartley can be reached on 571-272-0616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALMA PIPIC/Primary Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Sep 21, 2022
Application Filed
Jun 07, 2023
Response after Non-Final Action
Jul 13, 2025
Non-Final Rejection — §103
Oct 16, 2025
Response Filed
Oct 29, 2025
Final Rejection — §103
Feb 25, 2026
Request for Continued Examination
Mar 03, 2026
Response after Non-Final Action
Mar 05, 2026
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599673
TECHNIQUES FOR ENHANCING THE SELECTIVITY AND EFFICACY OF ANTIMICROBIAL AND ANTICANCER POLYMER AGENTS
2y 5m to grant Granted Apr 14, 2026
Patent 12583971
BIOSOURCED GELLING POLYAMIDES
2y 5m to grant Granted Mar 24, 2026
Patent 12557813
AGROCHEMICAL COMPOSITION OF TRIAZOLES
2y 5m to grant Granted Feb 24, 2026
Patent 12551441
Water Soluble Silicon-Containing Granulate
2y 5m to grant Granted Feb 17, 2026
Patent 12543739
UNIVERSAL PHOTODYNAMIC SPRAY COATINGS FOR INFECTION CONTROL
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
55%
Grant Probability
99%
With Interview (+56.9%)
3y 1m
Median Time to Grant
High
PTA Risk
Based on 696 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month